Post on 21-Dec-2015
transcript
TYPES OF MENTAL ILLNESS
“NEUROSES”
• NO BREAK WITH REALITY
• DEPRESSION, ANXIETY, SUBSTANCE ABUSE
• VERY COMMON
• CONTINUOUS NOT DISCRETE
• MUCH CO-MORBIDITY
MOOD
• EITHER (OR BOTH) PRESENCE OF NEGATIVE MOOD
• OR ABSENCE OF POSITIVE MOOD
PHYSICAL SYMPTOMS
• LOW ENERGY, FATIGUE
• SLEEP DISTURBANCES
• APPETITE DISTURBANCES
• VULNERABILITY TO MANY PHYSICAL ILLNESSES
PSYCHOLOGICAL SYMPTOMS
• EMOTIONAL - SADNESS, APATHY, LACK OF PLEASURE
• COGNITIVE - HOPELESSNESS AND HELPLESSNESS, LOW SELF-ESTEEM
• BEHAVIORAL - WITHDRAWAL, SUICIDE ATTEMPTS
TYPES
• MAJOR DEPRESSION - ABOVE• PSYCHOTIC - MORE SEVERE,
IMMOBILE, SUICIDAL• DYSTHYMIA - LONGER LASTING
(TWO YEARS), LOWER LEVEL• DISTRESS - REACTIVE TO LIFE
EVENT, GOES AWAY WHEN CONDITIONS CHANGE, NOT A DISORDER
CAUSES
• VARIED
• SOME GENETIC
• EARLY LOSS EVENTS AND ABUSE
• CURRENT LOSSES OR TRAUMAS
CHARACTERISTICS
• GREAT VARIANCE ACROSS SOCIETIES (3% - 30%)
• IN U.S. 10% EACH YEAR; 20% OVER LIFETIME
• 2/3 WOMEN
• INVERSE WITH SOCIAL CLASS
• MOST AMONG YOUNG, ELDERLY
PROGNOSIS (COURSE)
• COURSE HIGHLY VARIABLE
• MDD FREQUENT AND CHRONIC
• DYSTHYMIA CHRONIC
• DISTRESS ENDS WITH POSITIVE EVENTS OR ADJUSTMENT
TREATMENT
• TREATED WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI) - PROZAC, PAXIL, XOLOFT
• NOT MORE EFFECTIVE THAN OLDER DRUGS
• BETTER TOLERATED, LESS ADDICTIVE, FEWER OVERDOSES
• HIGHER RISK OF SUICIDE?
TREATMENT (CONT.)
• COGNITIVE THERAPY
• PSYCHOTHERAPY
• COMBINATION OF DRUGS AND PSYCHOLOGICAL THERAPY MIGHT BE BEST
SYMPTOMS
• PSYCHOLOGICAL
• UNEASE, FEAR, ANXIOUSNESS, DREAD
• PHYSICAL
• HEART PALPITATIONS, TREMBLING, STOMACH UPSET, FAINTING
MAJOR TYPES
• PHOBIAS - INTENSE FEAR OF A SPECIFIC OBJECT OR SITUATION
• PANIC - SITUATIONAL, EPISODIC
• OBSESSIVE-COMPULSIVE - PREOCCUPYING THOUGHTS OR BEHAVIORS
• GENERALIZED ANXIETY DISORDER
COMORBIDITY
• VERY HIGH COMORBIDITY WITH DEPRESSION
• MOST DEPRESSED PEOPLE ALSO ANXIOUS
• ANXIOUS PEOPLE OFTEN DEPRESSED
CHARACTERISTICS
• GREAT VARIANCE ACROSS SOCIETIES
• IN U.S. 20% EACH YEAR, 30% OVER LIFETIME
SOCIAL CHARACTERISTICS
• 2/3 FEMALE
• HIGH ETHNIC VARIATION
• E.G. BLACKS MORE PHOBIAS, HISPANICS MORE PANIC, JEWS MORE OBSESSIVE-COMPULSIVE
TREATMENT
• MEDICATION
• ANTI-ANXIETY - XANAX
• SSRI’S
• BEHAVIOR THERAPY
SUBSTANCE DEPENDENCE/ABUSE
• DEPENDENCE
• FREQUENT AND EXCESSIVE USE
• GROWING TOLERANCE/PROBLEMS WITH WITHDRAWAL
• ABUSE
• PROBLEMATIC CONSEQUENCES OF USE - FAMILY, WORK, LEGAL
CHARACTERISTICS
• ALCOHOL ABUSE OR DEPENDENCE - 10% YEAR, 25% LIFETIME
• DRUG ABUSE OR DEPENDENCE - 3% YEAR; 12% LIFETIME
CHARACTERISTICS
• 2/3 MALE
• YOUNG PEOPLE
• MIXED RESULTS ON SOCIAL CLASS
• MUCH ETHNIC VARIATION
• E.G. ISLAMIC, ASIANS, JEWS LITTLE, IRISH AND EASTERN EUROPE MUCH, BLACKS CURVILINEAR
TREATMENT
• VARIATION IN TREAT OR PUNISH?
• MUCH TREATMENT INVOLUNTARY
• GROUP THERAPY - AA
• LESS MEDICATION